Plant-derived chelators and ionophores as potential therapeutics for metabolic diseases

被引:3
|
作者
Lee, Vanessa J. [1 ]
Janisse, Samuel E. [1 ]
Heffern, Marie C. [1 ]
机构
[1] Univ Calif Davis, Dept Chem, One Shields Ave, Davis, CA 95616 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
INDUCED HEPATIC DAMAGE; WILSONS-DISEASE; IRON CHELATORS; IN-VITRO; ANTIOXIDANT ACTIVITY; OXIDATIVE STRESS; DIETARY LIGNANS; METAL CHELATORS; CARDIOVASCULAR-DISEASE; BIOLOGICAL-ACTIVITIES;
D O I
10.1039/d3cs00167a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Transition metal dysregulation is associated with a host of pathologies, many of which are therapeutically targeted using chelators and ionophores. Chelators and ionophores are used as therapeutic metal-binding compounds which impart biological effects by sequestering or trafficking endogenous metal ions in an effort to restore homeostasis. Many current therapies take inspiration or derive directly from small molecules and peptides found in plants. This review focuses on plant-derived small molecule and peptide chelators and ionophores that can affect metabolic disease states. Understanding the coordination chemistry, bioavailability, and bioactivity of such molecules provides the tools to further research applications of plant-based chelators and ionophores.
引用
收藏
页码:3927 / 3945
页数:19
相关论文
共 50 条
  • [1] Plant-derived therapeutics for the treatment of metabolic syndrome
    Graf, Brittany L.
    Raskin, Ilya
    Cefalu, William T.
    Ribnicky, David M.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (10) : 1107 - 1115
  • [2] Plant-Derived Lectins as Potential Cancer Therapeutics and Diagnostic Tools
    Mazalovska, Milena
    Kouokam, J. Calvin
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [3] Plant-Derived Extracellular Vesicles as Potential Emerging Tools for Cancer Therapeutics
    Ding, Lin
    Chang, Chih-Jung
    Liang, Min-Li
    Dong, Kang-Mei
    Li, Fu-Rong
    ADVANCED THERAPEUTICS, 2024,
  • [4] Plant-Derived Compounds as Promising Therapeutics for Vitiligo
    Pang, Yaobin
    Wu, Shi
    He, Yingjie
    Nian, Qing
    Lei, Jing
    Yao, Yejing
    Guo, Jing
    Zeng, Jinhao
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [5] The therapeutic potential of typical plant-derived compounds for the management of metabolic disorders
    Roy, Debajyoti
    Kaur, Prabhjot
    Ghosh, Maitrayee
    Choudhary, Deepika
    Rangra, Naresh Kumar
    PHYTOTHERAPY RESEARCH, 2024, 38 (08) : 3986 - 4008
  • [6] Phenylpropanoid Sucrose Esters: Plant-Derived Natural Products as Potential Leads for New Therapeutics
    Panda, P.
    Appalashetti, M.
    Judeh, Z. M. A.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (21) : 3234 - 3251
  • [7] Editorial: The mechanism of plant-derived polysaccharides regulating the obesity and metabolic diseases in humans
    Zhang, Guiguo
    Lee, Yunkyoung
    Liu, Yang
    Hao, Yanling
    FRONTIERS IN NUTRITION, 2022, 9
  • [8] Recent Patents on Plant-Derived Nanoparticles and their Potential Application Towards Various Cancer Therapeutics
    Santhosh, S. B.
    Shanmugarama, Santny
    Ramesh, Nimma
    Tharik, A. Mohamed Sheik
    Basamshetty, Veera Vijaya
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2023, 18 (03) : 292 - 306
  • [9] Plant-derived RNAi therapeutics: A strategic inhibitor of HBsAg
    Zhang, Shuo
    Sang, Xiaolin
    Hou, Dongxia
    Chen, Jinmei
    Gu, Hongwei
    Zhang, Yujing
    Li, Jing
    Yang, Darong
    Zhu, Haizhen
    Yang, Xiao
    Wang, Fangyu
    Zhang, Chunni
    Chen, Xi
    Zen, Ke
    Zhang, Chen-Yu
    Hong, Zhi
    BIOMATERIALS, 2019, 210 : 83 - 93
  • [10] Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review
    Patil, Ashwani S.
    Mahajan, Umesh B.
    Agrawal, Yogeeta O.
    Patil, Kalpesh R.
    Patil, Chandragouda R.
    Ojha, Shreesh
    Sharma, Charu
    Goyal, Sameer N.
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 132